These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29530082)

  • 21. Non-compliance to Mass Drug Administration Associated with the Low Perception of the Community Members About their Susceptibility to Lymphatic Filariasis in Ankobra, Ghana.
    Dicko I; Coulibaly YI; Sangaré M; Sarfo B; Nortey PA
    Infect Disord Drug Targets; 2020; 20(2):167-174. PubMed ID: 30727921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana.
    Biritwum NK; Garshong B; Alomatu B; de Souza DK; Gyapong M; Kyelem D
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005619. PubMed ID: 28493966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis.
    Krentel A; Gyapong M; McFarland DA; Ogundahunsi O; Titaley CR; Addiss DG
    Int Health; 2020 Dec; 13(Supplement_1):S55-S59. PubMed ID: 33349882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.
    Babu BV; Babu GR
    Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):538-49. PubMed ID: 24728444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya.
    Kusi C; Steinmann P; Merten S
    Infect Dis Poverty; 2020 Mar; 9(1):22. PubMed ID: 32114985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
    Regu K; Showkath Ali MK; Rajendran R; Koya SM; Ganesh B; Dhariwal AC; Lal S
    J Commun Dis; 2006 Dec; 38(4):333-8. PubMed ID: 17913209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets.
    Jones C; Ngasalla B; Derua YA; Tarimo D; Malecela MN
    Int J Infect Dis; 2017 Aug; 61():38-43. PubMed ID: 28527817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration.
    Derua YA; Kisinza WN; Simonsen PE
    Parasit Vectors; 2018 Jul; 11(1):429. PubMed ID: 30029675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.
    Njomo DW; Kimani BW; Kibe LW; Okoyo C; Omondi WP; Sultani HM
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0009012. PubMed ID: 33370300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
    Babu BV; Kar SK
    Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of mass drug administration on elimination of lymphatic filariasis in Surat city, India.
    Vaishnav KG; Desai HS; Srivastava PK; Joshi PT; Kurian G; Thakor HG; Dhariwal AC
    J Commun Dis; 2012 Dec; 44(4):251-9. PubMed ID: 25145075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COMMUNITY MEMBERS' PERCEPTIONS OF MASS DRUG ADMINISTRATION FOR CONTROL OF LYMPHATIC FILARIASIS IN RURAL AND URBAN TANZANIA.
    Kisoka WJ; Tersbøl BP; Meyrowitsch DW; Simonsen PE; Mushi DL
    J Biosoc Sci; 2016 Jan; 48(1):94-112. PubMed ID: 25790081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India.
    Babu BV; Satyanarayana K
    Trop Doct; 2003 Apr; 33(2):79-82. PubMed ID: 12680538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of factors related to individuals who were never treated during mass drug administration for lymphatic filariasis in Ambon City, Indonesia.
    Titaley CR; Worrell CM; Ariawan I; Taihuttu YMJ; de Lima F; Naz SF; Que BJ; Krentel A
    PLoS Negl Trop Dis; 2022 Nov; 16(11):e0010900. PubMed ID: 36367853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.
    Krentel A; Fischer PU; Weil GJ
    PLoS Negl Trop Dis; 2013 Nov; 7(11):e2447. PubMed ID: 24278486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphatic filariasis elimination programme in Andaman and Nicobar Islands, India: drug coverage and compliance post eight rounds of MDA.
    Sunish IP; Shriram AN; Sivan A; Kartick C; Saha BP; Vijayachari P
    Trop Doct; 2013 Jan; 43(1):30-2. PubMed ID: 23550201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India.
    Bashar A; Nandekar SV; Shrivastava P; Singh RN; Srikrishnan P
    J Vector Borne Dis; 2023; 60(3):307-316. PubMed ID: 37843242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge and perceptions about lymphatic filariasis: a study during the programme to eliminate lymphatic filariasis in an urban community of Orissa, India.
    Rath K; Nath N; Shaloumy M; Swain BK; Suchismita M; Babu BV
    Trop Biomed; 2006 Dec; 23(2):156-62. PubMed ID: 17322817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bridging the gap in outreach and compliance with mass drug administration for lymphatic filariasis elimination in an endemic district in Kerala, India: an intervention research approach.
    Nandha B; Meenakshy V; Abdul Khader N; Vijayakumar KN; Jambulingam P
    Health Educ Res; 2019 Jun; 34(3):300-309. PubMed ID: 30805648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs.
    Kastner RJ; Stone CM; Steinmann P; Tanner M; Tediosi F
    PLoS Negl Trop Dis; 2015; 9(10):e0004147. PubMed ID: 26451729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.